Valuation: Medios AG

Market Cap 270M 314M 252M 231M 434M 30.04B 441M 2.97B 1.16B 15.06B 1.18B 1.15B 49.81B P/E 2026 *
11.9x
P/E 2027 * 8.81x
Enterprise Value 357M 417M 334M 306M 576M 39.82B 585M 3.94B 1.54B 19.97B 1.56B 1.53B 66.03B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.14x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+0.55%
1 week-3.51%
Current month+0.18%
1 month-11.29%
3 months-15.38%
6 months-36.19%
Current year-24.03%
1 week 10.84
Extreme 10.84
11.54
1 month 10.8
Extreme 10.8
12.9
Current year 10.8
Extreme 10.8
17.44
1 year 10.8
Extreme 10.8
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 57 10/06/2021
Date Insider Type Main position Quantity % Market Cap.
12/8/26 Buy

Chief Financial Officer

3,500 0.0137%
4/2/26 Sell

Chief Executive Officer

13,638 0.0535%
22/1/26 Buy

Executive/Senior Manager

4,000 0.0157%
Change 5-day change 1-year change 3-year change Capi.($)
-0.54%-3.51%-21.65%-28.48% 314M
+4.46%+4.92%+82.07%+134.31% 1,141B
+0.85%+4.81%+53.77%+58.51% 659B
+2.72%+6.92%+28.99%+77.15% 470B
+1.80%+0.52%+41.20%+44.05% 366B
+1.24%+2.35%+25.99%+42.21% 302B
+2.07%+2.97%+2.27%+13.06% 254B
+4.02%+6.29%+49.67%+68.96% 239B
+1.05%-0.02%-13.96%-52.13% 207B
+2.90%+8.63%+25.11%+94.52% 183B
Average +1.78%+3.34%+27.35%+45.21% 382.13B
Weighted average by Cap. +1.53%+4.31%+47.05%+74.13%

Financials

2026 *2027 *
Net sales 2.16B 2.52B 2.02B 1.85B 3.48B 240B 3.53B 23.78B 9.31B 121B 9.45B 9.24B 399B 2.21B 2.58B 2.06B 1.89B 3.56B 246B 3.62B 24.35B 9.54B 124B 9.67B 9.46B 408B
Net income 22.83M 26.61M 21.32M 19.56M 36.78M 2.54B 37.38M 252M 98.49M 1.28B 99.92M 97.75M 4.22B 30.68M 35.77M 28.65M 26.29M 49.43M 3.42B 50.24M 338M 132M 1.71B 134M 131M 5.67B
Net Debt 87.81M 102M 81.99M 75.23M 141M 9.78B 144M 968M 379M 4.91B 384M 376M 16.22B 45.33M 52.84M 42.33M 38.83M 73.03M 5.05B 74.23M 499M 196M 2.53B 198M 194M 8.38B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
868
Date Price Change Volume
19/08/26 EUR 11.00 -0.54% 61,704
18/08/26 EUR 11.06 +0.91% 26,173
17/08/26 EUR 10.96 -3.69% 44,003
14/08/26 EUR 11.38 +0.53% 27,435
13/08/26 EUR 11.32 -0.70% 49,321
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
11.00EUR
Average target price
21.00EUR
Spread / Average Target
+90.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock